Connexio Health
  • Home
  • Company
    • About
    • History
    • Careers
  • Solutions
    • Downstream Demand Generation
    • Virtual Clinical Education
    • Data Intelligence
    • Virtual Account Management
  • Resources
    • Articles
    • Case Studies
    • Whitepapers
    • Go-to-Market Growth Quiz
    • FAQs
    • Connexio Pulse Podcasts
  • Contact
  • Connexio Health and Alpha Sophia Announce Strategic Partnership to Bridge HCP Insights and Activation 

    Connexio Health and Alpha Sophia Announce Strategic Partnership to Bridge HCP Insights and Activation 

    [October 2025] – Connexio Health and Alpha Sophia today announced a strategic partnership designed to transform how healthcare manufacturers identify, engage, and activate healthcare professionals (HCPs). 

    By combining Alpha Sophia’s robust mapping, analytics, and targeting framework with Connexio Health’s downstream marketing and education capabilities, the collaboration delivers a seamless, end-to-end HCP engagement solution—from insight to activation. 

    “Together, we’re closing the gap between intelligence and action,” said a Connexio Health spokesperson. “Our shared approach enables clients to translate deep audience insights into meaningful engagement that drives measurable results.” 

    Alpha Sophia’s platform integrates more than 100 data sources to map the entire U.S. healthcare landscape, providing precise segmentation and targeting. Connexio Health complements this with fractional sales and marketing solutions that connect manufacturers and healthcare professionals to accelerate growth and expand reach. 

    This partnership creates a full-funnel engagement stack—empowering organizations to move from insight to impact with confidence. 

    Kristen Fescoe

    October 22, 2025
    Connexio Health, News
    Data, DataConnex, News, Partnership
  • 3 Jobs Every Pharma & Med Tech Leader Must Nail Before 2026

    3 Jobs Every Pharma & Med Tech Leader Must Nail Before 2026

    For pharma and med tech leaders, 2026 isn’t a distant horizon — it’s around the corner. Planning cycles are tightening, budgets are being finalized, and commercial teams are already laying the groundwork for next year’s performance.

    But readiness isn’t about checking boxes or building bigger dashboards. It’s about ensuring the right work is done now — so you don’t spend Q1 catching up while competitors move ahead.

    Here are the three jobs that matter most before January.



    1. Align Field Resources to Growth Priorities

    Field teams are the engine of commercial success — but even the strongest team can’t deliver if coverage doesn’t match opportunity.

    Many organizations enter Q1 with territories misaligned, leaving whitespace untouched and key accounts underserved. The result? Missed engagement, slower adoption, and room for competitors to gain traction.

    What to do now:

    • Reassess coverage maps against 2026 growth targets.
    • Use data-driven segmentation to identify whitespace and high-potential accounts.
    • Build flexibility into your model — through hybrid coverage or field augmentation — to maintain reach without increasing cost.

    The brands that win in 2026 will be those that treat field coverage not as a fixed structure, but as a strategic lever for growth.

    📘 Explore more:

    Winning the Healthcare Market: A Strategic Guide to Sales & Marketing ReadinessDownload


    2. Turn Data Into Actionable Insight

    Pharma and med tech teams have never had more data — and yet many still struggle to turn that data into meaningful action.

    CRM metrics, claims feeds, prescribing trends, utilization data — all essential, but often fragmented. The job now is to transform this volume into clarity.

    What to do now:

    • Connect disparate data sources to build a unified commercial view.
    • Identify leading indicators that predict performance, not just describe it.
    • Focus analytics on “what to do next,” not “what already happened.”

    When data is simplified into clear next steps, field teams execute faster, marketers target smarter, and leadership makes decisions with confidence.

    📄 Explore more:

    Healthcare Sales Forecasting: A Practical Guide to Setting Clear Goals and Metrics for Program PerformanceDownload


    3. Build Engagement Strategies That Earn Trust

    HCP engagement expectations are evolving rapidly. Physicians don’t want more touchpoints — they want meaningful ones.

    The leaders who succeed in 2026 will integrate personal, digital, and educational interactions into a single, cohesive experience that builds credibility and drives behavior change.

    What to do now:

    • Audit your engagement mix — are digital and in-person efforts working together or in silos?
    • Focus content and cadence on HCP needs, not internal metrics.
    • Measure consistency and value, not just reach.

    Consistency creates trust — and trust drives lasting commercial success.

    🎧 Listen to learn more



    Final Thought

    The 2026 countdown isn’t about more activity — it’s about smarter execution.

    Align your field to your future, turn data into direction, and engage in ways that build trust. Do these three jobs before Q1, and you’ll enter 2026 not just ready — but ahead.

    Kristen Fescoe

    October 6, 2025
    Connexio Health, Data and Technology, Marketing, Non-Personal Promotion, VSO
    Healthcare marketing, Non Personal Promotion, Sales Strategy
  • Why September is the Best Time to Plan for 2026

    Why September is the Best Time to Plan for 2026

    In both healthcare and business, success doesn’t come from chance—it comes from preparation. The organizations that thrive are the ones that don’t just act but also step back to optimize and plan before the competition.

    Momentum Doesn’t Wait for January


    Many leaders treat strategic planning as a December or January exercise. The problem? By then, the market has already shifted, competitors have acted, and opportunities may have passed.

    Momentum isn’t created by reacting late. It’s built proactively, with thoughtful planning done before the year closes.

    That’s why September—when there’s still time to assess results, adjust strategies, and prepare for the year ahead—is the best moment to get ahead.

    From Implementation to Optimization

    Implementing a solution is only the starting point. The real gains come when organizations:

    • Optimize what’s working so it delivers even greater impact.
    • Evolve what isn’t so that weaknesses don’t carry into the next year.
    • Build readiness to adapt quickly when new challenges and opportunities appear.

    This is where the investment of time and resources begins to generate compounding returns.

    Why Early Planning Wins

    Getting started before the year closes delivers three major advantages:

    • Clarity: You’ll know what’s effective—and what isn’t—while there’s still time to adjust.
    • Momentum: January becomes a launchpad, not a scramble.
    • Confidence: Teams can execute with focus instead of reacting under pressure.

    Ready to Lead, Not React

    September isn’t just another month—it’s a turning point. By planning early, organizations can enter the new year with clarity, alignment, and a competitive edge.

    Your 2026 success story doesn’t start in January. It starts now.

    Kristen Fescoe

    September 18, 2025
    Uncategorized
    Healthcare marketing, Marketing, Non Personal Promotion, Sales Strategy
  • From Diagnosis to Deployment: A Smarter Treatment Plan for Your Healthcare Marketing 

    From Diagnosis to Deployment: A Smarter Treatment Plan for Your Healthcare Marketing 

    In healthcare, identifying a problem is only half the battle. The same holds in healthcare marketing. 

    You’ve run the diagnostics—maybe you’re missing whitespace opportunities, struggling with underperforming non-personal promotion (NPP), or juggling too many disjointed tools. You know something isn’t working. 

    Now comes the most important part: choosing the right treatment plan—and executing it with precision. 

    Step One: Diagnose the Real Issue

    Too often, brands attempt a “more is more” approach—more outreach, more tools, more spend—without aligning any of it to the root cause.

    Here are a few symptoms we see frequently:

    • Low engagement on HCP campaigns despite repeated outreach
    • Fragmented data sources that don’t communicate or update in real time
    • Stalled pipeline growth due to overlooked whitespace or misaligned targeting
    • Inconsistent field team execution across markets

    If any of these sound familiar, you’re not alone. But treating symptoms won’t deliver long-term health—you need
    a strategic prescription.

    Step Two: Match the Solution to the Symptom

    At Connexio Health, we’ve developed a menu of treatments tailored to specific pain points. These aren’t one-size-fits-all tools—they’re configurable solutions designed to create measurable business outcomes.

    Your Treatment Menu:

    SymptomConnexio Solution Outcome
    Missed WhitespaceWhitespace ConnexIdentify and prioritize hidden high-value targets
    Underperforming NPPMarketing ConnexOrchestrate targeted, omnichannel campaigns
    Disjointed ToolsData Connex Unify and enrich data for smarter decision-making
    Product Compliance & Onboarding GapsIFU Connex Drive IFU compliance and seamless customer adoption

    These aren’t just fixes—they’re growth levers. And they’re already helping clients increase engagement, uncover market potential, and streamline execution.


    Step Three: Build Your Plan and Execute

    Having the right prescription is important—but execution is everything.

    We recommend a phased approach:

    Phase 1: Quick Wins (Now–Q4)

    • Activate whitespace targets to test lift
    • Optimize an existing campaign using clean, enriched data
    • Align your messaging across NPP and field

    Phase 2: Foundational Fixes (Q1 and beyond)

    • Consolidate data sources under a single intelligence layer
    • Expand outreach strategy to include new markets or verticals
    • Establish a repeatable, insight-driven playbook for 2025 planning

    Your success depends on aligning the right people, platforms, and performance benchmarks. The good news?

    You don’t have to do it alone.

    Real Results: From Test to Transformation

    One of our clients—an emerging biotech—started with a pilot in a single region. With Whitespace Connex and a targeted NPP strategy, they saw a 38% increase in qualified HCP interactions in just eight weeks. That regional success scaled into a national program—and laid the groundwork for future product launches.

    Start small. Scale smart. See measurable results.

    Ready to Start Your Treatment Plan?

    If you’re ready to move from awareness to action, let’s talk. Our team can help you assess your current challenges, pinpoint the right solutions, and create a path to measurable growth.

    Connect with us to learn more.


    Kristen Fescoe

    August 25, 2025
    Marketing, Healthcare Manufacturing, Non-Personal Promotion
    Healthcare, Healthcare marketing, Marketing
  • Healthcare Transformation Lab: Boosting Reach Through Virtual Engagement

    Healthcare Transformation Lab: Boosting Reach Through Virtual Engagement

    In today’s rapidly evolving healthcare landscape, reaching the right stakeholders with the right message at the right time is more complex than ever. Field teams remain a cornerstone of engagement, but even the most seasoned representatives face limitations—time, geography, access, and bandwidth. As we strive for more meaningful, sustained connections in an omnichannel world, Virtual Account Management (VAM) has emerged as a powerful complement, enabling organizations to expand their reach, deepen relationships, and unlock new levels of performance.

    The Case for Virtual Account Management

    While field teams offer invaluable face-to-face interaction, they often face access restrictions, particularly in specialty areas where providers are time-constrained or dispersed. Virtual Account Management fills critical gaps, allowing healthcare organizations to:

    1. Maintain continuity between in-person visits through strategic digital touchpoints.
    2. Engage hard-to-reach providers who may not be accessible through traditional rep channels.
    3. Prioritize accounts more intelligently, focusing high-touch field resources where they’ll have the greatest impact.


    With a VAM layer in place, teams can extend coverage, deliver consistent messaging, and adapt more nimbly to the evolving access environment.

    Field + Virtual: A Force Multiplier


    When done right, virtual account managers do more than echo field messages—they amplify them. This hybrid model fosters coordination and balance between roles:

    1. Field reps focus on high-value, relationship-driven engagements.
    2. Virtual managers reinforce brand messaging, address follow-up needs, and introduce new resources across multiple channels.

    Together, they create a surround-sound experience that fosters trust and guides providers through the decision-making process.

    Data-Driven Precision

    Integrating virtual account management with data intelligence tools—such as predictive segmentation, whitespace identification, and next-best-action algorithms—supercharges targeting strategies. By leveraging insights from prescribing trends, engagement history, and clinical behavior, organizations can determine:

    1. Which accounts warrant in-person vs. virtual engagement?
    2. What content resonates best at each stage of the provider journey?
    3. How to time and sequence interactions for maximum impact.

    This kind of precision ensures field and virtual teams operate in lockstep, reducing redundancy and boosting ROI.

    Results That Speak

    Healthcare organizations that adopt hybrid models often report measurable gains:

    1. Improved coverage across under-engaged territories.
    2. Increased HCP engagement rates, particularly among digitally native or access-limited specialists.
    3. Enhanced agility, allowing commercial teams to pivot rapidly in response to market changes or product needs.

    In short, virtual account management isn’t a replacement for field force—it’s an evolution. One that empowers teams to work smarter, adapt faster, and ultimately deliver better outcomes for providers and patients alike.

    Closing Thought

    In an era where personalization, access, and agility reign supreme, augmenting field teams with virtual account management is not just a trend—it’s a transformation. Those who embrace this model will find themselves better equipped to meet the moment—and the future—of healthcare engagement.

    Kristen Fescoe

    August 4, 2025
    VSO, Whitespace
    Sales organization, Sales Strategy
  • 2026 Is Closer Than You Think: Why Now Is the Time to Start Planning

    2026 Is Closer Than You Think: Why Now Is the Time to Start Planning

    For commercial teams in healthcare, July isn’t just the heart of summer—it’s the unofficial start of planning season.

    Sure, the calendars still say 2025. However, smart healthcare manufacturers recognize that by the time Q4 arrives, the pressure is on, calendars are full, and strategy shifts from building momentum to managing urgency. That’s why now is the time to start the conversation around 2026.

    Why Early Planning Matters in Healthcare

    The healthcare landscape continues to evolve at a breakneck pace—from tightening access and rising commercialization costs to shifting provider expectations and new specialty product launches. Waiting until Q4 to develop your 2026 strategy risks missing critical opportunities to:

    • Identify whitespace and high-potential HCPs
    • Reevaluate segmentation and targeting models
    • Align budget assumptions with updated market dynamics
    • Prepare your team for a new wave of non-personal engagement tactics

    Early strategy work creates breathing room for creativity, alignment, and data-driven decision making. It’s not about moving faster—it’s about moving smarter.

    How Connexio Supports Strategy That Scales

    At Connexio, we work with healthcare manufacturers across the planning lifecycle to bring clarity, confidence, and structure to the process. Whether you’re refining your go-to-market approach, recalibrating territory models, or rethinking brand engagement in a digital-first world, we help you:

    • Turn raw data into insight through our Data Connex engine
    • Identify missed opportunities via Whitespace Connex
    • Optimize omnichannel outreach with Marketing Connex
    • Build repeatable frameworks that grow with your brand

    Our team doesn’t just help you plan—we help you win.

    Three Questions to Ask Now


    As you look toward 2026, consider these starting points for internal alignment:

    • What would it look like to go into Q4 already aligned and action-ready?
    • When does our team traditionally start strategy conversations, and is that working for us?
    • Are we still making planning decisions based on outdated market assumptions?

    Let’s Start the Conversation


    Whether you’re building a brand plan, reshaping field strategy, or just trying to get ahead of the Q4 crunch, Connexio is here to help you turn today’s planning into tomorrow’s performance.

    📅 Let’s talk 2026 readiness

    Kristen Fescoe

    July 10, 2025
    Connexio Health, Marketing
  • 5 Trends Reshaping Healthcare in 2025

    5 Trends Reshaping Healthcare in 2025

    The healthcare industry is undergoing a rapid transformation, driven by innovation, policy shifts, and rising demands for personalized, equitable care. For manufacturers, providers, and healthcare strategists, understanding what’s changing—and why—is critical to navigating this evolving landscape.

    At Connexio Health, we’ve identified five high-impact trends shaping the future of healthcare in 2025. These are not just buzzwords—they’re actionable insights influencing strategy, investment, and engagement across the industry.

    1. AI in Action: From Potential to Practical

    Artificial intelligence has moved beyond the experimental phase and is now deeply embedded in daily healthcare workflows. Hospitals and health systems use AI to support diagnostic accuracy, streamline prior authorizations, predict patient deterioration, and optimize administrative operations.

    Pharmaceutical companies leverage generative AI to personalize healthcare provider (HCP) communication and accelerate content creation. However, the success of these initiatives hinges on high-quality data, governance, and ethical implementation.

    Why it matters:

    Organizations that embed AI into decision-making processes—and invest in strong data infrastructure—will be better positioned to scale innovation responsibly and sustainably.

    2. Digital HCP Engagement Is the New Standard

    The shift toward digital-first engagement strategies continues to accelerate. As physicians face increasing time constraints and digital preferences rise, traditional sales rep access becomes less reliable.

    In response, life sciences companies invest in precision non-personal promotion (NPP), omnichannel strategies, and content tailored to provider behavior. HCPs now expect relevant, timely, and coordinated messaging across digital channels—on their schedule, not the brand’s.

    Why it matters:

    Those who embrace data-driven, omnichannel approaches will build stronger HCP relationships and drive better engagement outcomes.

    3. Health Equity as a Business Imperative

    What started as a public health and policy movement has become a strategic priority. Health equity is now central to the mission of healthcare organizations, with measurable goals tied to access, outcomes, and representation.

    From inclusive clinical trials to localized population health data, companies are taking a more intentional approach to addressing disparities, both as a moral obligation and a performance benchmark.

    Why it matters:

    Equity is no longer an initiative; it’s a core KPI. Meeting regulatory expectations and building trust with diverse communities will require ongoing commitment and transparency.

    4. Specialty Drugs Reshape Access and Affordability

    Specialty medications—particularly in oncology, rare diseases, and gene therapy—dominate pipelines and redefine access strategies. With higher costs and more complex patient journeys, these therapies require coordinated support systems that address coverage, affordability, education, and physician awareness.

    Manufacturers must collaborate across stakeholders to reduce barriers, streamline prior authorization processes, and empower providers with actionable information at the point of care.

    Why it matters:

    Access is no longer just about coverage. It’s about how effectively stakeholders can enable appropriate, timely use of high-value therapies.

    5. Value-Based Care Gets More Granular

    Value-based care (VBC) continues to evolve, moving beyond broad primary care and hospital metrics into more specialized domains. Payers and providers are increasingly focused on condition-specific and population-based payment models that reward outcomes, not volume.

    This evolution impacts pharma, as real-world evidence, patient-reported outcomes, and total cost of care become essential elements of value demonstration, particularly for high-cost, high-impact therapies.

    Why it matters:

    Tailoring engagement strategies to support value-based models—especially in specialty and chronic care—will be a competitive differentiator in 2025 and beyond.

    Looking Ahead

    These five trends represent a convergence of technology, policy, and cultural expectations that are redefining healthcare. Organizations that stay agile, insight-driven, and patient-centered will be best equipped to thrive in this next phase of transformation.

    📩 Contact us to learn more or explore how we can support your next step in this evolving landscape.

    Kristen Fescoe

    June 4, 2025
    Connexio Health, Data and Technology
  • A Quick Guide to Medicare Part 2: Medicare Gaps, Enrollment Timing & Strategic Opportunities

    A Quick Guide to Medicare Part 2: Medicare Gaps, Enrollment Timing & Strategic Opportunities

    In Part 1 of our Medicare series, we outlined the four parts of Medicare and how each affects healthcare delivery and patient access. In this second part, we focus on coverage gaps, strategic enrollment timelines, and how stakeholders can align their programs to support the evolving needs of Medicare beneficiaries.

    Enrollment Timelines Impact Care Transitions

    The Initial Enrollment Period (IEP) spans 3 months before and after the month a person turns 65. Delays in enrollment, particularly for Parts B and D, can create coverage gaps or penalties, affecting continuity of care.

    Why it matters for stakeholders: Aligning patient outreach and medication education efforts with key enrollment windows can significantly improve engagement, adherence, and patient satisfaction.

    What’s Missing? Recognizing the Gaps in Medicare Coverage

    Even with robust benefits, traditional Medicare doesn’t cover:

    • Long-term custodial care
    • Routine dental, vision, and hearing
    • Care received outside the U.S.
    • Cosmetic procedures

    Why it matters: These gaps can lead to underdiagnosis, fragmented care, or deferred treatments, presenting opportunities for supplemental services, education, and engagement programs.

    Medigap: Filling the Financial Gaps

    For those enrolled in Original Medicare (Parts A & B), Medigap policies help manage deductibles, coinsurance, and other out-of-pocket costs. However, they cannot be used with Medicare Advantage plans.

    Strategic opportunity: Providers and support teams can play a pivotal role in helping patients navigate these complex choices to balance affordability, access, and long-term value.

    Medicare’s Strategic Impact on Healthcare Innovation

    Medicare is not just a payer—it’s a catalyst for healthcare innovation. Its structure affects:

    • How new therapies are evaluated and reimbursed
    • Patient access pathways and market entry strategies
    • Design of value-based and preventative care programs

    By understanding the Medicare landscape, stakeholders can:

    • Anticipate access barriers
    • Tailor messaging and support materials
    • Design patient support programs aligned with reimbursement realities
    • Enable better outcomes for aging populations


    Final Thoughts

    Medicare’s role in the healthcare ecosystem will only become more significant as the U.S. population continues to age. Whether you’re driving clinical innovation or optimizing commercial strategies, knowing how Medicare works—and where it falls short—will be essential.

    At Connexio Health, we help stakeholders navigate this landscape with actionable data, engagement strategies, and insights that empower better access and outcomes.

    Let’s collaborate to fill the gaps, support smarter decision-making, and deliver more for Medicare beneficiaries.

    Kristen Fescoe

    May 26, 2025
    Connexio Health
  • A Quick Guide to Medicare Part I: Supporting Smarter Patient Engagement

    A Quick Guide to Medicare Part I: Supporting Smarter Patient Engagement

    As over 66 million Americans now rely on Medicare for their healthcare needs, understanding how this complex program works isn’t just a personal necessity—it’s a strategic imperative for healthcare leaders. For providers, manufacturers, and pharmaceutical teams, the Medicare landscape shapes everything from patient engagement to market access strategies.

    Whether you’re advising patients approaching retirement or developing programs and therapies for a 65+ population, here’s what you need to know.

    Medicare Basics: A Quick Refresher

    Medicare is the U.S. federal health insurance program primarily for individuals aged 65 and older, though it also covers younger individuals with certain disabilities or chronic conditions. It’s divided into four parts, each with unique implications for healthcare access and financial planning.

    Fast Facts for Healthcare Leaders:

    • 66M+ Americans are currently enrolled in Medicare (2024).
    • The average out-of-pocket cost per beneficiary is around $6,500 annually.
    • Coverage gaps (like dental, vision, and long-term care) can influence patient behavior and outcomes.

    The Four Parts of Medicare—and What They Mean for Engagement

    Part A: Hospital Insurance

    Covers: Inpatient hospital stays, short-term skilled nursing care, hospice, and limited home health services.
    Implications: Most beneficiaries qualify for $0 monthly premiums, but rising deductibles ($1,632 in 2025) may drive cost sensitivity, especially among fixed-income patients.

    Part B: Medical Insurance

    Covers: Outpatient services, preventive care, diagnostics, mental health, and medical equipment.
    Implications: Patients are responsible for 20% of most services post-deductible, highlighting the need for education around cost-sharing and financial assistance.

    Part C: Medicare Advantage

    Covers: All Part A and B services, usually Part D, and often extras like dental, vision, and wellness benefits.
    Implications: Plans vary widely by region and provider network. Manufacturers and providers must align access strategies with local plan details.

    Part D: Prescription Drug Coverage

    Covers: Most outpatient prescription medications and some vaccines.
    Implications: Formularies and coverage vary by plan. Understanding patient affordability and access is essential, especially for specialty medications.

    Coming Up in Part 2…

    We’ll explore Medicare’s impact on enrollment timing, care transitions, and innovation—as well as what’s missing from coverage and how the healthcare industry can help fill the gaps.


    Kristen Fescoe

    May 22, 2025
    Connexio Health
  • Tariffs and the Healthcare Ripple Effect: What Manufacturers Must Know 

    Tariffs and the Healthcare Ripple Effect: What Manufacturers Must Know 

    Tariffs may seem like geopolitical headlines or economic policy levers, but they have immediate and measurable effects for healthcare manufacturers. From increasing costs on essential materials to forcing shifts in commercialization models, tariffs can dramatically alter go-to-market strategies. 

    At Connexio Health, we help medical device, pharmaceutical, diagnostic, and biotech innovators respond to disruption with agility. Here’s what healthcare manufacturers need to know—and do—when tariffs are in play. 

    The True Cost of Tariffs in Healthcare 

    Tariffs are government-imposed duties on imported goods. When these apply to materials used in healthcare products, such as electronic components, active pharmaceutical ingredients, or packaging supplies, they impact everything from unit economics to launch timelines. 

    A diagnostic manufacturer sourcing overseas electronic parts may face higher costs and delays. A pharmaceutical company reliant on foreign ingredients could see its supply chain destabilized. Even if a product is entirely U.S.-made, packaging, shipping,g and labeling components might still be tariff-affected. 

    These impacts extend beyond the supply chain. Increased costs may erode the margin or require price adjustments. For provider organizations under value-based care pressures, this can create friction, especially when outcomes, reimbursement, and budgets are under scrutiny. 

    The Commercial Model Under Pressure 

    Research from the Alexander Group shows how leading companies react to tariff-induced disruptions. According to their findings, 83 percent of affected firms permanently adjusted their commercial strategies. These changes include: 

    • Accelerated use of virtual sales and account management models 
    • Tighter account segmentation to focus on high-margin opportunities 
    • Investment in analytics to optimize territory planning and resource deployment 

    This shift isn’t temporary. As global instability, inflation, and tariff risk persist, manufacturers must design commercial models that flex and adapt. 

    Three Moves to Make Right Now 

    Whether your company is already feeling the impact of tariffs or simply planning for volatility, there are immediate steps you can take: 

    1. Audit Your Supply Chain 

    Map your current supplier base and assess exposure to tariff-related cost increases. Consider alternatives or backup sources that allow for faster pivots. 

    2. Rethink Pricing and Profitability 

    Work with your finance and sales leadership to review pricing models. Where are margins at risk? What are the thresholds your customer base will tolerate? Consider bundling, subscription models, or value-based pricing structures. 

    3. Reposition Your Sales Messaging 

    Equip your commercial teams with messaging that highlights product value, clinical outcomes, and economic benefit. With many providers operating under tighter budgets, clarity around total cost of ownership and ROI is critical. 

    The Connexio Health Advantage 

    At Connexio Health, we specialize in commercialization strategies that account for complexity. Whether you’re launching into a competitive space, navigating uncertain economic conditions, or realigning your sales force, we bring the insights and execution support you need to stay ahead. 

    Tariffs may be outside your control, but how you respond is not. Now is the time to assess, adapt, and accelerate. 

    To learn more about commercialization strategies that accelerate success, visit connexiohealth.com. 

    Kristen Fescoe

    May 13, 2025
    Distribution, Healthcare Manufacturing, Uncategorized
    Hot Topic, Manufacturers, Sales organization, Sales Strategy
1 2 3
Next Page
  • 607-545-4010
  • info@connexiohealth.com
  • FAQs
  • Privacy Policy
  • Terms & Conditions
  • Facebook
  • https://twitter.com/ConnexioHealth
  • Instagram
  • YouTube
  • LinkedIn